share_log

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Lowers Price Target to $8

HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Lowers Price Target to $8

HC Wainwright & Co.維持買入Sensus Healthcare,將目標股價下調至8美元
Benzinga ·  2023/08/07 06:25

HC Wainwright & Co. analyst Yi Chen maintains Sensus Healthcare (NASDAQ:SRTS) with a Buy and lowers the price target from $10 to $8.

HC Wainwright & Co. 分析師陳毅維持Sensus Healthcare(納斯達克股票代碼:SRTS)的買入,並將目標股價從10美元下調至8美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論